Pro-inflammatory Model
Pro-inflammatory Model - Related Videos
03:41
An Air Pouch Mouse Model for Lipopolysaccharide-Induced Inflammatory Exudate Collection
0 Views •
2025
This video describes the procedure for generating an air pouch in the subcutaneous tissue of mice and collecting inflammatory exudates in response to lipopolysaccharide administration in vivo. This video also covers the analysis of the neutrophil infiltration in the air pouch.
09:04
DNBS/TNBS Colitis Models: Providing Insights Into Inflammatory Bowel Disease and Effects of Dietary Fat
0 Views •
Cited by 92 •
2014
DNBS/TNBS induced colitis offers an alternative and inexpensive method to study the pathobiology of inflammatory bowel disease. The protocol discussed in this paper outlines the successful application of DNBS to induce colitis in mice and rats and allows one to thoroughly study host-mediated intestinal responses.
04:27
Generating a Pro-Inflammatory Organ Culture Model to Simulate an Early Intervertebral Disc Disease
0 Views •
2025
This video demonstrates a technique for culturing bovine intervertebral discs in bioreactors to develop a three-dimensional organ culture model. Specific nutrient-deprived media and degenerative pressure conditions are applied to the discs, mimicking the pro-inflammatory and degenerative microenvironment observed during early-stage intervertebral disc disease. The disc heights are measured post-treatment to analyze the effects of nutrient deprivation and degenerative loading.
12:43
On-Chip Endothelial Inflammatory Phenotyping
0 Views •
Cited by 3 •
2012
Microfluidic flow chambers etched by photolithography and fabricated from PDMS are applied to probe functional outcomes associated with EC dysfunction and inflammation. In a representative experiment, the ability of differential shear stress to modulate monocytic cell adhesion to cytokine activated EC monolayers is demonstrated.
05:02
Modeling Brain Metastasis Via Tail-Vein Injection of Inflammatory Breast Cancer Cells
0 Views •
Cited by 8 •
2021
We describe a xenograft mouse model of breast cancer brain metastasis generated via tail-vein injection of an endogenously HER2-amplified inflammatory breast cancer cell line.
FAQs
Inflammatory stimulation can increase the release of cytokines and other mediators from neural or supporting cells. These signals may change neuronal function, modify glial activity, and disturb tissue homeostasis. Studying the sequence from immune activation to cellular change helps researchers identify which inflammatory events may contribute to neurological dysfunction.
Cytokines and related mediators provide molecular evidence that inflammatory signaling has been activated. Their release links the initiating stimulus to downstream effects in neurons, glia, and surrounding tissue. Measuring these responses can therefore help distinguish molecular activation from later cellular or behavioral consequences and clarify how inflammation participates in disease-related processes.
A model can be used to examine relationships among the inflammatory stimulus, mediator release, cellular responses, neuronal function, glial activity, and tissue homeostasis. Researchers can also compare these molecular and cellular changes with behavioral outcomes. This multilevel view is useful because inflammation may influence nervous-system function through several connected biological processes rather than one isolated event.
A typical study establishes controlled inflammatory signaling in neural or supporting cells, then evaluates the resulting molecular, cellular, and, when relevant, behavioral changes. Researchers can compare these outcomes with conditions in which an anti-inflammatory intervention is introduced. The workflow connects the initiating immune response with measurable consequences and treatment-related changes.
These models are relevant when researchers want to examine inflammation associated with neurodegeneration, pain, infection, injury, or neurological disease. They provide a controlled setting for asking whether inflammatory signaling contributes to altered neural function or tissue imbalance. The resulting evidence can help prioritize disease mechanisms for further study and support therapeutic evaluation.
Researchers can use the model to determine whether an intervention changes inflammatory mediator release or limits downstream effects on neurons, glia, tissue homeostasis, or behavior. Comparing outcomes with and without treatment provides evidence about therapeutic activity. In neuroscience, this approach helps connect suppression of inflammation with possible protection from disease-related functional changes.